Monday, June 19 • 1:15pm - 1:45pm
#135: PAREXEL International Innovation Theater: Developing Drugs in the New Era of Personalized Medicines

Sign up or log in to save this to your schedule and see who's attending!

Feedback form is now closed.
Component Type: Session

Over the next five years, personalized medicines in development are expected to increase to nearly 70%, according to the Tufts Center for the Study of Drug Development (TCSDD), potentially improving drug safety and efficacy and also the likelihood of approval. Genomic-guided or supported drug development is a new paradigm requiring companies to think beyond traditional drug development models. This presentation focuses on critical skills to successfully make this transformation.


PAREXEL International

avatar for Anita Nelsen

Anita Nelsen

Vice President, Translational Medicine, Parexel
Anita has more than 20 years of experience in the pharmaceutical industry and 29 years of experience in pharmacogenetic, human and molecular genetics research in roles including bench scientist, manager, and business leader. As Head of Translational Medicine Services, Anita leads... Read More →
avatar for Sy Pretorius

Sy Pretorius

Executive Vice President, Chief Medical and Scientific Officer, Parexel
y Pretorius is the CMO & CSO at PAREXEL. As a member of the executive team, he is responsible for the overall leadership of several service lines & business units. Sy is passionate about drug development and leads several company-wide initiatives focused on clinical trial and drug... Read More →

Monday June 19, 2017 1:15pm - 1:45pm
Theater #1 McCormick Place 2301 South Martin Luther King Jr. Drive, Gate 4 Chicago, IL 60616